Track topics on Twitter Track topics that are important to you
Prof McArthur speaks with ecancer at WCCS 2016 about targetted medicine to reduce melanoma mutational burden, with specific focus on the BRIM trials of cobimetinib and vemurafinib. He outlines the expansion of personalised therapy and genotyping for...
Original Article: Targetted medicine to reduce melanoma mutational burdenNEXT ARTICLE
There are three main types of skin cancer: basal cell carcinoma, squamous cell carcinoma and malignant melanoma. Basal cell carcinoma Basal cell carcinoma, or BCC, is a cancer of the basal cells at the bottom of the epidermis. It’s very common ...